These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28537888)

  • 41. MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).
    Zhang W; Zhang M; Liu L; Jin D; Wang P; Hu J
    Med Sci Monit; 2018 Oct; 24():7137-7145. PubMed ID: 30293085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.
    Yang C; Sun C; Liang X; Xie S; Huang J; Li D
    Cancer Gene Ther; 2016 Apr; 23(4):90-7. PubMed ID: 26964645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
    Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S
    Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.
    Petriella D; De Summa S; Lacalamita R; Galetta D; Catino A; Logroscino AF; Palumbo O; Carella M; Zito FA; Simone G; Tommasi S
    Tumour Biol; 2016 Apr; 37(4):5503-13. PubMed ID: 26566629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
    Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
    Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
    Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
    J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
    Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G
    Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
    Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p.
    Li J; Tang Z; Wang H; Wu W; Zhou F; Ke H; Lu W; Zhang S; Zhang Y; Yang S; Ni S; Huang J
    Biomed Pharmacother; 2018 Jan; 97():1182-1188. PubMed ID: 29136957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer.
    Gao ZJ; Yuan WD; Yuan JQ; Yuan K; Wang Y
    Pathol Res Pract; 2018 May; 214(5):700-705. PubMed ID: 29567332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses.
    Liang CY; Li ZY; Gan TQ; Fang YY; Gan BL; Chen WJ; Dang YW; Shi K; Feng ZB; Chen G
    Respir Res; 2020 Feb; 21(1):60. PubMed ID: 32102656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis.
    Cai T; Long J; Wang H; Liu W; Zhang Y
    Oncol Rep; 2017 Aug; 38(2):1213-1223. PubMed ID: 28656287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrative Analysis of NSCLC Identifies LINC01234 as an Oncogenic lncRNA that Interacts with HNRNPA2B1 and Regulates miR-106b Biogenesis.
    Chen Z; Chen X; Lei T; Gu Y; Gu J; Huang J; Lu B; Yuan L; Sun M; Wang Z
    Mol Ther; 2020 Jun; 28(6):1479-1493. PubMed ID: 32246902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
    Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.